Article Details

Indivior enters sparse cannabis use disorder pipeline with $30M upfront for Aelis rights deal

Retrieved on: 2021-06-08 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Indivior enters sparse cannabis use disorder pipeline with $30M upfront for Aelis rights deal. View article details on hiswai:

Excerpt

Indivior will pay Aelis Farma $30 million upfront with the potential for $100 million-plus in biobucks following a phase 2b trial of a cannabis use ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up